Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALEMBICLTD | NSE
-2.01
-2.15%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
91.42
94.26
94.32
91.00
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. Alembic Limited was founded in 1907 and is based in Vadodara India. Alembic Limited is a subsidiary of Nirayu Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
36.0%1 month
55.2%3 months
41.1%6 months
32.5%12.29
-
1.57
0.00
0.00
28.46
21.29
-
659.90M
23.56B
246.10M
1.74
35.25
25.40
37.80
12.60
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
11.96
Range1M
24.54
Range3M
30.41
Rel. volume
0.41
Price X volume
12.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 41.72 | 23.05B | -2.27% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 368.55 | 23.00B | 3.38% | n/a | 2.49% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 181.1 | 22.33B | -3.22% | 69.03 | 68.84% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 477.5 | 20.69B | -4.24% | n/a | 107.90% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.34 | 19.01B | -3.48% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 860.05 | 18.04B | -3.86% | 35.85 | 0.81% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 576.55 | 16.67B | -0.46% | 52.36 | 0.60% |
| Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 949.6 | 12.69B | -5.00% | 16.58 | 8.48% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1492 | 12.69B | 1.00% | 104.15 | 83.75% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 605.55 | 12.13B | -0.96% | 13.55 | 0.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.46 | 24.85 | Par |
| Ent. to Revenue | 21.29 | 11.40 | Expensive |
| PE Ratio | 12.29 | 51.36 | Cheaper |
| Price to Book | 1.57 | 6.83 | Cheaper |
| Dividend Yield | 1.74 | 0.52 | Leader |
| Std. Deviation (3M) | 41.06 | 42.17 | Par |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 23.56B | 290.82B | Emerging |